The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Structure and function of serotonin G protein-coupled receptors
Open accessAbstract
Serotonin receptors are prevalent throughout the nervous system and the periphery, and remain one of the most lucrative and promising drug discovery targets for disorders ranging from migraine headaches to neuropsychiatric disorders such as schizophrenia and depression. There are 14 distinct serotonin receptors, of which 13 are G protein coupled receptors (GPCRs), which are targets for approximately 40% of the approved medicines. Recent crystallographic and biochemical evidence has provided a converging understanding of the basic structure and functional mechanics of GPCR activation. Currently, two GPCR crystal structures exist for the serotonin family, the 5-HT1B and 5-HT2B receptor, with the antimigraine and valvulopathic drug ergotamine bound. The first serotonin crystal structures not only provide the first evidence of serotonin receptor topography but also provide mechanistic explanations into functional selectivity or biased agonism. This review will detail the findings of these crystal structures from a molecular and mutagenesis perspective for driving rational drug design for novel therapeutics incorporating biased signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,003
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100 · cited 6×
“…A uthor M anuscript receptor subtypes, with the exception of 5-HT5b, are expressed, and they are involved in the modulation of sleep-wake cycles, emesis, appetite, mood, memory, breathing (Ray et al., 2011), cognition, and many other functions (Berger et al., 2009; Meltzer and Roth, 2013).”
InfluentialSelf-citationCrystal structure of the human β2 adrenergic G-protein-coupled receptor
Rasmussen, S. G. F., Choi, H.-J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., et al. (2007) · Nature · doi:10.1038/nature06325 · Cited by 1,930
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
PEROUTKA, S. J., & SNYDER, S. H. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13812-1 · Cited by 1,360
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
Structure of a β1-adrenergic G-protein-coupled receptor
Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R., Leslie, A. G. W., Tate, C. G., & Schertler, G. F. X. (2008) · Nature · doi:10.1038/nature07101 · Cited by 1,344
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., & Saxena, P. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90207-8 · Cited by 1,258
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Chien, E. Y. T., Liu, W., Zhao, Q., Katritch, V., Won Han, G., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., et al. (2010) · Science · doi:10.1126/science.1197410 · Cited by 1,128
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationTHE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. L. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,103
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
The probable arrangement of the helices in G protein-coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 972
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
Liu, W., Chun, E., Thompson, A. A., Chubukov, P., Xu, F., Katritch, V., Han, G. W., Roth, C. B., Heitman, L. H., IJzerman, A. P., et al. (2012) · Science · doi:10.1126/science.1219218 · Cited by 945
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895 · cited 1×
“…pathways through Gαi, Gαq/11, and Gαs, allowing this receptor family to modulate several biochemical signaling pathways, and leading to several physiological consequences, a discussion which is beyond the scope of this review, (but see Nichols and Nichols (2008) for a more comprehensive review).”
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Structure of the human κ-opioid receptor in complex with JDTic
Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X.-P., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 879
Self-citationTWO KINDS OF TRYPTAMINE RECEPTOR
GADDUM, J. H., & PICARELLI, Z. P. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00142.x · Cited by 847
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
Structure of the human histamine H1 receptor complex with doxepin
Shimamura, T., Shiroishi, M., Weyand, S., Tsujimoto, H., Winter, G., Katritch, V., Abagyan, R., Cherezov, V., Liu, W., Han, G. W., et al. (2011) · Nature · doi:10.1038/nature10236 · Cited by 804
The Dynamic Process of β2-Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 796
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W. I., Okada, T., Kobilka, B. K., Haga, T., et al. (2012) · Nature · doi:10.1038/nature10753 · Cited by 792
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Self-citationERSPAMER, V., & ASERO, B. (1952) · Nature · doi:10.1038/169800b0 · Cited by 670
Urban, D. J., & Roth, B. L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124803 · Cited by 668
Self-citationStructure of the δ-opioid receptor bound to naltrindole
Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I., & Kobilka, B. K. (2012) · Nature · doi:10.1038/nature11111 · Cited by 667
Crystal Structure of a Lipid G Protein–Coupled Receptor
Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G., Desale, H., Clemons, B., Cahalan, S. M., Schuerer, S. C., et al. (2012) · Science · doi:10.1126/science.1215904 · Cited by 666
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Self-citationPedigo, N. W., Yamamura, H. I., & Nelson, D. L. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb02397.x · Cited by 627
5-HT3 receptors are membrane ion channels
Derkach, V., Surprenant, A., & North, R. A. (1989) · Nature · doi:10.1038/339706a0 · Cited by 625
Activation mechanism of the β2-adrenergic receptor
Dror, R. O., Arlow, D. H., Maragakis, P., Mildorf, T. J., Pan, A. C., Xu, H., Borhani, D. W., & Shaw, D. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110499108 · Cited by 623
A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS
Woolley, D. W., & Shaw, E. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.4.228 · Cited by 602
Langley, J. N. (1905) · The Journal of Physiology · doi:10.1113/jphysiol.1905.sp001128 · Cited by 602
The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor
Fargin, A., Raymond, J. R., Lohse, M. J., Kobilka, B. K., Caron, M. G., & Lefkowitz, R. J. (1988) · Nature · doi:10.1038/335358a0 · Cited by 597
Choudhary, M. S., Craigo, S., Sibley, D. R., Roth, B. L., Monsma, F. J., Shen, Y., Uluer, A., & Meltzer, H. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/74zp-ze10 · Cited by 592
Self-citationOpiate Agonists and Antagonists Discriminated by Receptor Binding in Brain
Pert, C. B., Pasternak, G., & Snyder, S. H. (1973) · Science · doi:10.1126/science.182.4119.1359 · Cited by 546
Banasr, M., Hery, M., Printemps, R., & Daszuta, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300320 · Cited by 539
Serotonin Content of Some Mammalian Tissues and Urine and a Method for Its Determination
Twarog, B. M., & Page, I. H. (1953) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1953.175.1.157 · Cited by 532
Structural Basis for Molecular Recognition at Serotonin Receptors
Wang, C., Jiang, Y., Ma, J., Wu, H., Wacker, D., Katritch, V., Han, G. W., Liu, W., Huang, X.-P., Vardy, E., et al. (2013) · Science · doi:10.1126/science.1232807 · Cited by 528
Self-citationIdentification of Two Serine Residues Involved in Agonist Activation of the β-Adrenergic Receptor
Strader, C. D., Candelore, M. R., Hill, W. S., Sigal, I. S., & Dixon, R. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80035-7 · Cited by 523
Desensitization of G-protein-coupled Receptors
Xiao, Z., Yao, Y., Long, Y., & Devreotes, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1440 · Cited by 521
Kobilka, B. K., Frielle, T., Collins, S., Yang-Feng, T., Kobilka, T. S., Francke, U., Lefkowitz, R. J., & Caron, M. G. (1987) · Nature · doi:10.1038/329075a0 · Cited by 515
Allosteric sodium in class A GPCR signaling
Katritch, V., Fenalti, G., Abola, E. E., Roth, B. L., Cherezov, V., & Stevens, R. C. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.03.002 · Cited by 511
Self-citationFunctional Selectivity and Biased Receptor Signaling
Kenakin, T. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 505
Molecular control of δ-opioid receptor signalling
Fenalti, G., Giguere, P. M., Katritch, V., Huang, X.-P., Thompson, A. A., Cherezov, V., Roth, B. L., & Stevens, R. C. (2014) · Nature · doi:10.1038/nature12944 · Cited by 497
Self-citationDrugs and Valvular Heart Disease
Roth, B. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068265 · Cited by 479 · cited 3×
“Ultimately with continued use, severe chronic side-effects can occur such as retroperitoneal fibrosis, pleuropulmonary fibrosis, and cardiac valvulopathy due to off-target activity at the 5-HT2B receptor (Roth, 2007; Rothman et al., 2000), which will be discussed in the next section.”
Self-citationStructure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Self-citationStructure of the human smoothened receptor bound to an antitumour agent
Wang, C., Wu, H., Katritch, V., Han, G. W., Huang, X.-P., Liu, W., Siu, F. Y., Roth, B. L., Cherezov, V., & Stevens, R. C. (2013) · Nature · doi:10.1038/nature12167 · Cited by 464
Self-citationHigh-resolution crystal structure of human protease-activated receptor 1
Zhang, C., Srinivasan, Y., Arlow, D. H., Fung, J. J., Palmer, D., Zheng, Y., Green, H. F., Pandey, A., Dror, R. O., Shaw, D. E., et al. (2012) · Nature · doi:10.1038/nature11701 · Cited by 455
Serial Femtosecond Crystallography of G Protein–Coupled Receptors
Liu, W., Wacker, D., Gati, C., Han, G. W., James, D., Wang, D., Nelson, G., Weierstall, U., Katritch, V., Barty, A., et al. (2013) · Science · doi:10.1126/science.1244142 · Cited by 455
Crystal structure of a photoactivated deprotonated intermediate of rhodopsin
Salom, D., Lodowski, D. T., Stenkamp, R. E., Trong, I. L., Golczak, M., Jastrzebska, B., Harris, T., Ballesteros, J. A., & Palczewski, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608022103 · Cited by 442
Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine
Fitzgerald, L. W., Burn, T. C., Brown, B. S., Patterson, J. P., Corjay, M. H., Valentine, P. A., Sun, J.-H., Link, J. R., Abbaszade, I., Hollis, J. M., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26444-0 · Cited by 440
Historical View on Ergot Alkaloids
Hofmann, A. (1978) · Pharmacology · doi:10.1159/000136803 · Cited by 424
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
Shukla, A. K., Xiao, K., & Lefkowitz, R. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.003 · Cited by 418
Thomsen, W. J., Grottick, A. J., Menzaghi, F., Reyes-Saldana, H., Espitia, S., Yuskin, D., Whelan, K., Martin, M., Morgan, M., Chen, W., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133348 · Cited by 402
The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State
Rovati, G. E., Capra, V., & Neubig, R. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029470 · Cited by 392
Serotonin 2B receptor is required for heart development
Nebigil, C. G., Choi, D.-S., Dierich, A., Hickel, P., Le Meur, M., Messaddeq, N., Launay, J.-M., & Maroteaux, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9508 · Cited by 381
G-protein-coupled receptors at a glance
Kroeze, W. K., Sheffler, D. J., & Roth, B. L. (2003) · Journal of Cell Science · doi:10.1242/jcs.00902 · Cited by 380
Self-citationImpaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition
Ray, R. S., Corcoran, A. E., Brust, R. D., Kim, J. C., Richerson, G. B., Nattie, E., & Dymecki, S. M. (2011) · Science · doi:10.1126/science.1205295 · Cited by 372
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
Allen, J. A., Yost, J. M., Setola, V., Chen, X., Sassano, M. F., Chen, M., Peterson, S., Yadav, P. N., Huang, X.-P., Feng, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104807108 · Cited by 350
Self-citationSpecies differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain
Hoyer, D., & Middlemiss, D. N. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90159-4 · Cited by 349
Ligand binding and micro-switches in 7TM receptor structures
Nygaard, R., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Schwartz, T. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.006 · Cited by 346
Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex
Willins, D. L., Deutch, A. Y., & Roth, B. L. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<79::aid-syn8>3.0.co;2-a · Cited by 345
Self-citationCelada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs · doi:10.1007/s40263-013-0071-0 · Cited by 323 · cited 11×
“The 5HT1A receptor has been implicated in anxiety, and as mentioned, novel anti-depressants and antipsychotics have begun to incorporate partial 5-HT1A agonist activity to enhance their efficacy in such diseases (Celada et al., 2013).”
InfluentialThe GPCR Network: a large-scale collaboration to determine human GPCR structure and function
Stevens, R. C., Cherezov, V., Katritch, V., Abagyan, R., Kuhn, P., Rosen, H., & Wüthrich, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3859 · Cited by 316
Ghanouni, P., Steenhuis, J. J., Farrens, D. L., & Kobilka, B. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101126198 · Cited by 311
Bonhaus, D. W., Bach, C., DeSouza, A., Salazar, F. H. R., Matsuoka, B. D., Zuppan, P., Chan, H. W., & Eglen, R. M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14977.x · Cited by 305
Setola, V., Hufeisen, S. J., Grande-Allen, K. J., Vesely, I., Glennon, R. A., Blough, B., Rothman, R. B., & Roth, B. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1223 · Cited by 304
Self-citationKrupnick, J. G., Goodman, O. B., Keen, J. H., & Benovic, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.15011 · Cited by 303
Weinshank, R. L., Zgombick, J. M., Macchi, M. J., Branchek, T. A., & Hartig, P. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3630 · Cited by 294
SERUM VASOCONSTRICTOR (SEROTONIN)
Rapport, M. M. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51208-x · Cited by 288
Roth, B. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00019-9 · Cited by 287
Self-citationAmisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
Abbas, A. I., Hedlund, P. B., Huang, X.-P., Tran, T. B., Meltzer, H. Y., & Roth, B. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1521-8 · Cited by 285
Self-citationRapport, M. M., Green, A. A., & Page, I. H. (1948) · Science · doi:10.1126/science.108.2804.329 · Cited by 276
Locating ligand-binding sites in 7tm receptors by protein engineering
Schwartz, T. W. (1994) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(94)90054-x · Cited by 274
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
Molineaux, S. M., Jessell, T. M., Axel, R., & Julius, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6793 · Cited by 261
Roth, B., Hanizavareh, S. M., & Blum, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 257
Self-citationEngineering GPCR signaling pathways with RASSLs
Conklin, B. R., Hsiao, E. C., Claeysen, S., Dumuis, A., Srinivasan, S., Forsayeth, J. R., Guettier, J.-M., Chang, W. C., Pei, Y., McCarthy, K. D., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1232 · Cited by 254
Self-citationPrimary pulmonary hypertension and fenfluramine use.
Brenot, F., Herve, P., Petitpretz, P., Parent, F., Duroux, P., & Simonneau, G. (1993) · Heart · doi:10.1136/hrt.70.6.537 · Cited by 251
Millan, M. J., Brocco, M., Gobert, A., & Dekeyne, A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1962-z · Cited by 248
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
Horvath, J., Fross, R. D., Kleiner‐Fisman, G., Lerch, R., Stalder, H., Liaudat, S., Raskoff, W. J., Flachsbart, K. D., Rakowski, H., Pache, J., et al. (2004) · Movement Disorders · doi:10.1002/mds.20201 · Cited by 243
PANCREATITIS INDUCED BY 5-AMINOSALICYLIC ACID
Deprez, P., Descamps, C., & Fiasse, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90620-x · Cited by 230
Yuan, S., Filipek, S., Palczewski, K., & Vogel, H. (2014) · Nature Communications · doi:10.1038/ncomms5733 · Cited by 227
BindingDB (2011) · PubMed · doi:10.7270/q2154fjq · Cited by 224
Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors
Allen, J. A., & Roth, B. L. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100553 · Cited by 216
Self-citationRoth, B. L., Craigo, S. C., Choudhary, M. S., Uluer, A., Monsma, F. J., Shen, Y., Meltzer, H. Y., & Sibley, D. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38596-4 · Cited by 214
Self-citationDuxon, M. S., Flanigan, T. P., Reavley, A. C., Baxter, G. S., Blackburn, T. P., & Fone, K. C. F. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00480-0 · Cited by 210
Bockaert, J., Sebben, M., & Dumuis, A. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10829-8 · Cited by 202
Cloning and functional characterization of the rat stomach fundus serotonin receptor.
Foguet, M., Hoyer, D., Pardo, L. A., Parekh, A., Kluxen, F. W., Kalkman, H. O., Stühmer, W., & Lübbert, H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05427.x · Cited by 195
PARTIAL PURIFICATION OF THE VASOCONSTRICTOR IN BEEF SERUM
Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57355-5 · Cited by 195
Desensitization of G protein-coupled receptors.
Freedman, N. J., & Lefkowitz, R. J. (1996) · PubMed · Cited by 190
Kursar, J. D., Nelson, D. L., Wainscott, D. B., Cohen, M. L., & Baez, M. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08969-2 · Cited by 186
The molecular evolution of G protein-coupled receptors: Focus on 5-hydroxytryptamine receptors
Peroutka, S. J., & Howell, T. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90060-4 · Cited by 182
Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine.
Jh, G. (1953) · PubMed · Cited by 182
Di Giovanni, G., Di Matteo, V., Di Mascio, M., & Esposito, E. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1<53::aid-syn7>3.0.co;2-2 · Cited by 179
Compan, V., Zhou, M., Grailhe, R., Gazzara, R. A., Martin, R., Gingrich, J., Dumuis, A., Brunner, D., Bockaert, J., & Hen, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2806-03.2004 · Cited by 178
Young, W. B., & Silberstein, S. D. (1997) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1997.3701015.x · Cited by 177
Shapiro, D. A., Kristiansen, K., Weiner, D. M., Kroeze, W. K., & Roth, B. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111675200 · Cited by 172
Self-citationAdham, N., Romanienko, P., Hartig, P., Weinshank, R. L., & Branchek, T. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08798-x · Cited by 171
Kursar, J. D., Nelson, D. L., Wainscott, D. B., & Baez, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09676-2 · Cited by 170
5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra
Bouhelal, R., Smounya, L., & Bockaert, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90799-6 · Cited by 163
Cloning and functional characterization of the human 5‐HT2B serotonin receptor
Schmuck, K., Ullmer, C., Engels, P., & Lübbert, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80590-3 · Cited by 158
Nebigil, C. G., Étienne-Selloum, N., Messaddeq, N., & Maroteaux, L. (2003) · The FASEB Journal · doi:10.1096/fj.02-1122fje · Cited by 158
Roth, B. L., Nakaki, T., Chuang, D., & Costa, E. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90244-2 · Cited by 157
Self-citationHuang, X., Setola, V., Yadav, P. N., Allen, J., Rogan, S. C., Hanson, B. J., Revankar, C. M., Robers, M., Doucette, C., & Roth, B. L. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058057 · Cited by 152
Self-citationMultiple mechanisms of serotonergic signal transduction
Roth, B. L., & Chuang, D. M. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90621-7 · Cited by 148
Self-citationMapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor
Almaula, N., Ebersole, B. J., Zhang, D., Weinstein, H., & Sealfon, S. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14672 · Cited by 147
Kohn, B., & Hofmann, A. (1981) · The Antioch Review · doi:10.2307/4638477 · Cited by 147
Mengod, G., Vilaró, M. T., Raurich, A., López‐Giménez, J. F., Cortés, R., & Palacios, J. M. (1996) · The Histochemical Journal · doi:10.1007/bf02272148 · Cited by 145
Bockaert, J., Dumuis, A., Bouhelal, R., Sebben, M., & Cory, R. N. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169129 · Cited by 142
Ouadid‐Ahidouch, H., Seguin, J. R., Dumuis, A., Bockaert, J., & Nargeot, J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08883-2 · Cited by 140
Nelson, D. L. G., Lucaites, V. L., Wainscott, D. B., & Glennon, R. A. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005315 · Cited by 139
Kroeze, W. K., & Roth, B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00132-2 · Cited by 136
Self-citationFirst Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Soergel, D. G., Subach, R. A., Sadler, B., Connell, J., Marion, A. S., Cowan, C. L., Violin, J. D., & Lark, M. W. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.207 · Cited by 134
Roth, B. L., Shoham, M., Choudhary, M. S., & Khan, N. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.259 · Cited by 133
Self-citationNew mouse 5‐HT2‐like receptor Expression in brain, heart and intestine
Loric, S., Launay, J., Colas, J., & Maroteaux, L. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80936-b · Cited by 130
Altieri, S. C., Garcia‐García, Á. L., Leonardo, E. D., & Andrews, A. M. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3002174 · Cited by 128
Nilsson, T., Longmore, J., Shaw, D. E., Olesen, I. J., & Edvinsson, L. I. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702773 · Cited by 125
THE RELATIVE ACTIVITIES OF SOME TRYPTAMINE ANALOGUES ON THE ISOLATED RAT STOMACH STRIP PREPARATION
Vane, J. R. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00933.x · Cited by 123
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs
Meltzer, H. Y., & Roth, B. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70678 · Cited by 123
Self-citationPharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Wainscott, D. B., Cohen, M. L., Schenck, K. W., Audia, J. E., Nissen, J. S., Baez, M., Kursar, J. D., Lucaites, V. L., & Nelson, D. L. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13628-6 · Cited by 122
Pardo, L., Deupí, X., Dölker, N., López-Rodríguez, M. L., & Campillo, M. (2006) · ChemBioChem · doi:10.1002/cbic.200600429 · Cited by 120
Hamblin, M. W., Metcalf, M. A., McGuffin, R. W., & Karpells, S. T. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90654-4 · Cited by 118
Kristiansen, K., Kroeze, W. K., Willins, D. L., Gelber, E. I., Savage, J. E., Glennon, R. A., & Roth, B. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39293-6 · Cited by 117
Self-citationChoudhary, M. S., Craigo, S., & Roth, B. L. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13653-5 · Cited by 115
Self-citationMustafi, D., & Palczewski, K. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051938 · Cited by 108
Mapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brain
Bonaventure, P., Hall, H., Gommeren, W., Cras, P. P., Langlois, X., Jurzak, M., & Leysen, J. E. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200004)36:1<35::aid-syn4>3.0.co;2-y · Cited by 107
5-HT receptor subtypes outside the central nervous system. Roles in the physiology of the gut.
Gershon, M. D., Wade, P. R., Kirchgessner, A. L., & Tamir, H. (1990) · PubMed · Cited by 106
5-ht5A receptors as a therapeutic target
Thomas, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.006 · Cited by 106
Kulla, A., & Manahan‐Vaughan, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.2.150 · Cited by 106
Johnson, M. P., Loncharich, R. J., Baez, M., & Nelson, D. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09924-9 · Cited by 104
Structure-Based Ligand Discovery Targeting Orthosteric and Allosteric Pockets of Dopamine Receptors
Lane, J. R., Chubukov, P., Liu, W., Canals, M., Cherezov, V., Abagyan, R. A., Stevens, R. C., & Katritch, V. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088054 · Cited by 100
5-Hydroxytryptamine 4(a) Receptor Is Coupled to the Gα Subunit of Heterotrimeric G13 Protein
Ponimaskin, E. G., Profirovic, J., Vaiškunaite, R., Richter, D. W., & Voyno-Yasenetskaya, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112216200 · Cited by 93
Armbruster, B. N., & Roth, B. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400030200 · Cited by 88
Self-citationChoudhary, M. S., Sachs, N. A., Uluer, A., Glennon, R. A., Westkaemper, R. B., & Roth, B. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08564-5 · Cited by 88
Self-citationClaeysen, S., Joubert, L., Sebben, M., Bockaert, J., & Dumuis, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200588200 · Cited by 78
Distribution of the 5-HT5A serotonin receptor mRNA in the human brain
Pasqualetti, M., Ori, M., Nardi, I., Castagna, M., Cassano, G. B., & Marazziti, D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00003-5 · Cited by 76
Almaula, N., Ebersole, B. J., Ballesteros, J. A., Weinstein, H., & Sealfon, S. C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09149-7 · Cited by 73
Receptor subtype and density determine the coupling repertoire of the 5-ht2 receptor subfamily
Lucaites, V. L., Nelson, D. L. G., Wainscott, D. B., & Baez, M. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00423-7 · Cited by 72
Levy, F. O., Gudermann, T. W., Birnbaumer, M., Kaumann, A. J., & Birnbaumer, L. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80379-u · Cited by 72
The action of enteramine on the heart of molluscs
Erspamer, V., & Ghiretti, F. (1951) · The Journal of Physiology · doi:10.1113/jphysiol.1951.sp004682 · Cited by 69
Differential coupling of 5‐HT1 receptors to G proteins of the Gi family
Lin, S. L., Setya, S., Johnson-Farley, N. N., & Cowen, D. S. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704809 · Cited by 69
Braden, M. R., & Nichols, D. E. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039255 · Cited by 68
Setola, V., Dukat, M., Glennon, R. A., & Roth, B. L. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009266 · Cited by 67
Self-citationStructure-Based Discovery of Selective Serotonin 5-HT 1B Receptor Ligands
Rodriguez, D. J., Brea, J. M., Loza, M. I., & Carlsson, J. (2014) · Structure · doi:10.1016/j.str.2014.05.017 · Cited by 65
The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor
JONES, P. G., CURTIS, C. A. M., & Hulme, E. C. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90036-5 · Cited by 64
Relevance of rhodopsin studies for GPCR activation
Deupí, X. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.09.002 · Cited by 64
The human serotonin 5‐HT2B receptor: Pharmacological link between 5‐HT2 and 5‐HT1D receptors
Choi, D., Birraux, G., Launay, J., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00968-6 · Cited by 56
Role of 5-HT5A receptors in the consolidation of memory
González, R., Chávez-Pascacio, K., & Meneses, A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.051 · Cited by 55
Ding, X., Zhao, X., & Watts, A. G. (2013) · Biochemical Journal · doi:10.1042/bj20121644 · Cited by 45
Smith, S. A., Waggoner, A. D., Fuentes, L. D. L., & Dávila‐Román, V. G. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2009.05.002 · Cited by 44
Purification of the substance which is responsible for the vasoconstrictor activity of serum.
Rapport, M. M., Green, A. A., & PAGE, I. H. (1947) · PubMed · Cited by 43
Functional coupling of a recombinant Human 5‐HT5A receptor to G‐proteins in HEK‐293 cells
Hurley, P., McMahon, R., Fanning, P., O’Boyle, K. M., Rogers, M. S., & Martin, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701928 · Cited by 39
Garnovskaya, M. N., Nebigil, C. G., Arthur, J. M., Spurney, R. F., & Raymond, J. R. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10241-1 · Cited by 39
Lindsley, C. W. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400107y · Cited by 36
Curtin, P. C. P., Medan, V., Neumeister, H., Bronson, D. R., & Preuss, T. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4733-12.2013 · Cited by 30
Cox, D. A., & Cohen, M. L. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00125-8 · Cited by 29
Gehret, A. U., Jones, B. W., Tran, P. N., Cook, L. B., Greuber, E. K., & Hinkle, P. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059733 · Cited by 27
Pharmacological Differentiation of Human 5-HT1B and 5-HT1D Receptors
Peroutka, S. J. (1994) · Neurosignals · doi:10.1159/000109569 · Cited by 26
Johnson, M. P., Wainscott, D. B., Lucaites, V. L., Baez, M., & Nelson, D. L. G. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00115-0 · Cited by 25
5‐Hydroxytryptamine stimulation of phospholipase D activity in the rabbit isolated mesenteric artery
Hinton, J. M., Adams, D., & Garland, C. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702484 · Cited by 13
The Safety and Efficacy of Lorcaserin in the Management of Obesity
Hess, R., & Cross, L. B. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.11.2713 · Cited by 10
Brudeli, B., Moltzau, L. R., Nguyen, C. H. T., Andressen, K. W., Nilsen, N. O., Levy, F. O., & Klaveness, J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.060 · Cited by 9
Cited by
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review
Hermanns, H., Hollmann, M. W., Stevens, M. F., Lirk, P., Brandenburger, T., Piegeler, T., & Werdehausen, R. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.06.014 · Cited by 338
Jiang, S.-H., Li, J., Dong, F.-Y., Yang, J.-Y., Liu, D.-J., Yang, X.-M., Wang, Y.-H., Yang, M.-W., Fu, X.-L., Zhang, X.-X., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.008 · Cited by 288
The serotonergic system and cognitive function
Švob Štrac, D., Pivac, N., & Mück-Šeler, D. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0007 · Cited by 285
Metadata
- Authors
- McCorvy, J. D., & Roth, B. L.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 150
- Pages
- 129-142
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2011312787
- Cited by
- 372
- References
- 175
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.